[go: up one dir, main page]

FI854179A0 - Antibakterieblandning och framstaellningsfoerfarande foer dess aktiva aemnen. - Google Patents

Antibakterieblandning och framstaellningsfoerfarande foer dess aktiva aemnen.

Info

Publication number
FI854179A0
FI854179A0 FI854179A FI854179A FI854179A0 FI 854179 A0 FI854179 A0 FI 854179A0 FI 854179 A FI854179 A FI 854179A FI 854179 A FI854179 A FI 854179A FI 854179 A0 FI854179 A0 FI 854179A0
Authority
FI
Finland
Prior art keywords
antibakterieblandning
aktiva
aemnen
och
bacteria
Prior art date
Application number
FI854179A
Other languages
English (en)
Other versions
FI86081C (fi
FI86081B (fi
FI854179L (fi
Inventor
Jean-Richard Neeser
Pierre Wuersch
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of FI854179A0 publication Critical patent/FI854179A0/fi
Publication of FI854179L publication Critical patent/FI854179L/fi
Application granted granted Critical
Publication of FI86081B publication Critical patent/FI86081B/fi
Publication of FI86081C publication Critical patent/FI86081C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/14Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
    • A01N43/16Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pest Control & Pesticides (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
FI854179A 1984-10-26 1985-10-25 Foerfarande foer framstaellning av glykopeptid eller oligosackarid, som aer aktivt mot patogena bakterier med fimbria av typ i. FI86081C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH513684 1984-10-26
CH5136/84A CH660557A5 (fr) 1984-10-26 1984-10-26 Composition anti-bacterienne et procede de preparation de ses constituants actifs.

Publications (4)

Publication Number Publication Date
FI854179A0 true FI854179A0 (fi) 1985-10-25
FI854179L FI854179L (fi) 1986-04-27
FI86081B FI86081B (fi) 1992-03-31
FI86081C FI86081C (fi) 1992-07-10

Family

ID=4288552

Family Applications (1)

Application Number Title Priority Date Filing Date
FI854179A FI86081C (fi) 1984-10-26 1985-10-25 Foerfarande foer framstaellning av glykopeptid eller oligosackarid, som aer aktivt mot patogena bakterier med fimbria av typ i.

Country Status (15)

Country Link
US (1) US4939123A (fi)
EP (1) EP0179324B1 (fi)
JP (1) JP2566913B2 (fi)
KR (1) KR910008798B1 (fi)
AT (1) ATE68501T1 (fi)
AU (1) AU577411B2 (fi)
CA (1) CA1280987C (fi)
CH (1) CH660557A5 (fi)
DE (1) DE3584414D1 (fi)
ES (2) ES8800360A1 (fi)
FI (1) FI86081C (fi)
IL (1) IL76628A (fi)
NO (1) NO164719C (fi)
PT (1) PT81372B (fi)
ZA (1) ZA857842B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2605185B1 (fr) * 1986-10-17 1993-08-20 Meiji Seika Kaisha Procede de culture des plantes
DE68910212T2 (de) * 1988-07-12 1994-03-03 Aquaspersions Ltd Bekämpfung unerwünschter Schädlinge.
US5041236A (en) * 1989-10-27 1991-08-20 The Procter & Gamble Company Antimicrobial methods and compositions employing certain lysozymes and endoglycosidases
EP0425016B1 (en) * 1989-10-27 1995-12-20 The Procter & Gamble Company Antimicrobial method and formulation employing type II endoglycosidase and antimicrobial agent
US5238843A (en) * 1989-10-27 1993-08-24 Genencor International, Inc. Method for cleaning a surface on which is bound a glycoside-containing substance
US5258304A (en) * 1989-10-27 1993-11-02 Genencor International, Inc. Method of removing microorganisms from surfaces with Type II endoglycosidase
US5141925A (en) * 1990-04-23 1992-08-25 Trustees Of Tufts College Vivo methods for treating coccidiosis
US5718909A (en) * 1991-02-18 1998-02-17 Medscand Ab Sheet containing carbohydrate derivative for removal of E. coli
US5500206A (en) * 1994-04-29 1996-03-19 The Procter & Gamble Company Oral compositions comprising actinomyces viscosus fimbriae
JP3576720B2 (ja) 1996-10-15 2004-10-13 株式会社東海理化電機製作所 ダイアル操作装置
JP3061616B1 (ja) * 1999-04-09 2000-07-10 株式会社セラリカ野田 低カロリ―調製ロ―ヤルゼリ―
FR2802536B1 (fr) * 1999-11-23 2003-06-13 Chru Lille Oligomannosides de synthese, leur preparation et leur utilisation a la detection d'anticorps et a la prevention d'infections
ITMI20030391A1 (it) * 2003-03-04 2004-09-05 S I I T S R L Servizio Internaz Ionale Imballa Formulazioni anticarie a base di faseolamina.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH14773A (en) * 1976-01-01 1981-12-09 Kureha Chemical Ind Co Ltd Protein-bound polysaccharides
JPS5576818A (en) * 1978-12-06 1980-06-10 Hitoshi Ito Agent for improving hepatic function
AU6770981A (en) * 1980-01-28 1981-08-17 Svensson, S. E. Isolation of carbohydrates from cell tissue
AU561066B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Antibacterial composition containing an oligosaccharide
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
EP0089940A1 (en) * 1982-03-23 1983-09-28 BioCarp AB Compositions for therapeutic or diagnostic use containing oligosaccharides
IT1168205B (it) * 1983-07-21 1987-05-20 Wellcome Italia Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione
US4613589A (en) * 1985-08-19 1986-09-23 Abbott Laboratories D-manno-2-octulosonic acid derivatives, pharmaceutical compositions and method of use
US4613590A (en) * 1985-08-19 1986-09-23 Abbott Laboratories Amino D-manno-2-octulopyranosidonate containing compounds, pharmaceutical compositions and method of use

Also Published As

Publication number Publication date
FI86081C (fi) 1992-07-10
ES8802458A1 (es) 1988-06-16
ATE68501T1 (de) 1991-11-15
EP0179324A2 (fr) 1986-04-30
US4939123A (en) 1990-07-03
CA1280987C (en) 1991-03-05
IL76628A (en) 1991-06-10
ES557292A0 (es) 1988-06-16
NO854273L (no) 1986-04-28
DE3584414D1 (de) 1991-11-21
JPS61103829A (ja) 1986-05-22
ZA857842B (en) 1986-05-28
PT81372A (fr) 1985-11-01
CH660557A5 (fr) 1987-05-15
AU577411B2 (en) 1988-09-22
IL76628A0 (en) 1986-02-28
ES8800360A1 (es) 1987-11-01
JP2566913B2 (ja) 1996-12-25
NO164719B (no) 1990-07-30
EP0179324A3 (en) 1988-05-18
KR910008798B1 (ko) 1991-10-21
KR860003269A (ko) 1986-05-21
PT81372B (pt) 1987-11-30
FI86081B (fi) 1992-03-31
ES548242A0 (es) 1987-11-01
AU4851485A (en) 1986-05-01
EP0179324B1 (fr) 1991-10-16
FI854179L (fi) 1986-04-27
NO164719C (no) 1990-11-07

Similar Documents

Publication Publication Date Title
FI854179L (fi) Antibakterieblandning och framstaellningsfoerfarande foer dess aktiva aemnen.
ES2032503T3 (es) Medicamento para la zona de la cavidad bucal. (reserva del art. 167.2 cpe).
ATE72988T1 (de) Fettsaeure-zusammensetzungen.
SE8602723D0 (sv) Thiazoles, their production and pharmaceutical compositions containing them
DE68909077D1 (de) Gamma-Linolensäure oder Dihomo-gamma-Linolensäure enthaltende Zubereitung zur Verbesserung der Haut.
EP0151989A3 (en) Means for the treatment of cardiac diseases
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
ATE38991T1 (de) In 2-stellung substituierte 1,3propyledendephosphonat-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
YU45708B (sh) Postopek za pripravo l-karnitina na mikrobiološki način in mikroorganizmi uporabni za ta postopek
ATE99669T1 (de) N-2,3-butadienyl-tri-aminoalkanderivate.
CO4980849A1 (es) Composiciones farmaceuticas -2-hidroximetil-1,3-oxatiolan-5-il)-(1h)-pirimidin-2-ona(la mivudina), y su uso en terapia medica
ATE141796T1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
DE3873232D1 (de) Ein dideoxynukleosid enthaltendes arzneimittel.
DK420187D0 (da) Oxiran-pseudooligosaccharider, deres fremstilling og anvendelse
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante
SU1455633A1 (ru) О,о-диизопропил-о-[1, 1-диметил-2-пропилтио-2-(о-о-диизопропилфосфорил)- имино]-этилфосфат, обладающий бактерицидной активностью
GR1002969B (el) Φαρμακευτικο παρασκευασμα βασιζομενο σε αιωρημα εμβρυικων κυτταρων με δραση ανοσοποιητικης υποκαταστασης και μεθοδος θεραπειας του συνδρομου της επικτητης μολυνσης ανοσοποιητικης ανεπαρκειας (hiv) με τη χρηση αυτου του παρασκευασματος.
SU1417444A1 (ru) 2,4-Дифенил-3(4-ацетокси-4-метилгексин-2-ил)-3-азабицикло [3,3,1]нонан-9-он, проявляющий противовоспалительную активность

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: SOCIETE DES PRODUITS NESTLE S.A.